title: Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab.
authors.affiliation: Heart Center Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany. frillinb@klilu.de
authors.forename: Birgit
authors.initials: B
authors.lastname: Frilling
authors.forename: Ralf
authors.initials: R
authors.lastname: Zahn
authors.forename: Boris
authors.initials: B
authors.lastname: Fraiture
authors.forename: Bernd
authors.initials: B
authors.lastname: Mark
authors.forename: Klaus
authors.initials: K
authors.lastname: Dönges
authors.forename: Torsten
authors.initials: T
authors.lastname: Becker
authors.forename: Karl E
authors.initials: KE
authors.lastname: Siegler
authors.forename: Karlheinz
authors.initials: K
authors.lastname: Seidl
authors.forename: Jörg
authors.initials: J
authors.lastname: Rustige
authors.forename: Jochen
authors.initials: J
authors.lastname: Senges
mesh_terms: D000077284:Abciximab; D000368:Aged; D000789:Angina, Unstable / Q000150:complications / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications* / Q000628:therapy*; D023921:Coronary Stenosis / Q000150:complications / Q000628:therapy; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000628:therapy; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000150:complications*
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077284:Abciximab